GCTK - CIK 0001506983
GlucoTrack, Inc. trades as GCTK. In its fiscal 2019 annual report the company posted revenue of $208.00K, down 100.0% from the prior year and net income of -$19.39M. This page tracks GlucoTrack, Inc. through 456 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 5 fiscal years GlucoTrack, Inc.'s revenue grew from $59.77K to $208.00K, a compound annual growth rate of 28.3%. Net profit margin expanded from -884.4% to 1690.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Major company event | 8-K | 2026-05-07 |
| EFFECT | - | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
The largest companies sharing GlucoTrack, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
GlucoTrack, Inc. reported revenue of $208.00K for fiscal year 2019, a decrease of 100.0% year over year.
In its latest fiscal year GlucoTrack, Inc. reported a net loss of $19.39M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.